ReviewCancers2021

Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase.

Sandeep Rana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.